APO 117 (Terazosin 5 mg)
Pill imprint APO 117 has been identified as Terazosin hydrochloride 5 mg.
Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; hyperhidrosis and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- APO 117
- Strength:
- 5 mg
- Color:
- Red
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antiadrenergic agents, peripherally acting
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Apotex Corp.
- National Drug Code (NDC):
- 60505-0117
- Inactive Ingredients:
- lactose monohydrate
corn starch
stearic acid
magnesium silicate
ammonia
ferrosoferric oxide
potassium hydroxide
propylene glycol
shellac
D&C Red No. 28
FD&C Red No. 40
gelatin
titanium dioxide
More about terazosin
Consumer resources
- Other brands: Hytrin
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
